852180-70-2 Usage
Uses
Used in Organic Synthesis:
[3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYL]METHANOL is used as a building block or intermediate in organic synthesis for the development of new compounds with specific properties and functions.
Used in Pharmaceutical Industry:
[3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYL]METHANOL is used as a potential active pharmaceutical ingredient or as a component in the synthesis of drug candidates due to its unique molecular structure and the presence of the 1,2,4-oxadiazole and phenyl rings.
Used in Material Science:
[3-(5-METHYL-1,2,4-OXADIAZOL-3-YL)PHENYL]METHANOL is used in material science for the development of new materials with specific characteristics, such as improved stability, reactivity, or other properties that can be beneficial in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 852180-70-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,2,1,8 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 852180-70:
(8*8)+(7*5)+(6*2)+(5*1)+(4*8)+(3*0)+(2*7)+(1*0)=162
162 % 10 = 2
So 852180-70-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H10N2O2/c1-7-11-10(12-14-7)9-4-2-3-8(5-9)6-13/h2-5,13H,6H2,1H3
852180-70-2Relevant articles and documents
BENZOTHIAZOLONE DERIVATIVES
-
, (2011/11/12)
Compounds of the formula I, in which R1, R2, R3, R3′, R4, R4′, E, E′, E″ and E′″ have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and ca
2-OXO-3-BENZYLBENZOXAZOL-2-ONE DERIVATIVES AND RELATED COMPOUNDS AS MET KINASE INHIBITORS FOR THE TREATMENT OF TUMOURS
-
Page/Page column 34, (2010/12/29)
Compounds of the formula (I), in which R1, R2, R3, R3′, R4, R4′, E, E′, E″ and E′″ have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumours.
THIADIAZINONE DERIVATIVES
-
Page/Page column 19, (2010/12/29)
Compounds of the formula (I), in which R1, Q and Het have the meanings indicated in Claim 1), are inhibitors of tyrosine kinases, in particular of Met kinase, and can be employed, inter alia, for the treatment of tumours.